We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Novo Nordisk A/S (NYSE:NVO) is ...

This effort aligns with the objectives of Saudi Vision 2030, which aims to address the clinical and economic challenges posed ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

A significant advancement in weight management has arrived for Singaporeans. Danish pharma Novo Nordisk has announced the ...

Drug major Cipla, led by MD and CEO Umang Vohra, is entering India's weight management segment and strengthening its CNS ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was approved for weight loss in March 2025 with a doctor’s prescription. The drug ...

A once-weekly growth hormone therapy improved growth-related endpoints for adolescents with multiple conditions of short ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.